GRAIL, Inc. (GRAL) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering GRAIL, Inc. (GRAL), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For GRAIL, Inc., analysts forecast revenue rising from $146.94M in 2025 to $490.53M in 2030; the average estimate for 2030 earnings per share is −$8.57; with published estimates ranging from −$9.97 to −$7.86; 10 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
GRAIL, Inc. (GRAL) forecast — frequently asked questions
What is the analyst price target for GRAIL, Inc.?
Analysts covering GRAIL, Inc. (GRAL) have a consensus price target of $115.29, 8.9% above the current price of $105.88. Published targets range from $60.00 to $175.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for GRAIL, Inc.'s earnings?
The average analyst estimate for GRAIL, Inc. (GRAL) earnings per share in 2030 is -8.57, with individual estimates between -9.97 and -7.86.
How much revenue is GRAIL, Inc. expected to make?
Analysts forecast GRAIL, Inc. (GRAL) revenue of $490.53M in 2030, based on 5 published estimates.
How many analysts cover GRAL?
10 analysts contribute estimates for GRAIL, Inc. (GRAL). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Diagnostics & Research stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.